SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Phaarmasia informs about press release

13 Aug 2024 Evaluate
Phaarmasia has informed that it enclosed copies of newspaper advertisement published on 13th August, 2024 regarding unaudited financial results for Quarter ended 30th June, 2024 as published in Business Standard (English newspaper) and Telugu Prabha (Telugu newspaper). This Information is also made available at the website of Company at http://phaarmasia.in/financial.html.

The above information is a part of company’s filings submitted to BSE.

Phaarmasia Share Price

107.24 0.00 (0.00%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1680.00
Dr. Reddys Lab 1223.30
Cipla 1231.00
Zydus Lifesciences 938.65
Lupin 2311.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×